Regeneron Pharmaceuticals, Inc.
MX ˙ BMV ˙ US75886F1075
SecurityMX:REGN / Regeneron Pharmaceuticals, Inc.
InstitutionPinnacle Associates Ltd
Latest Disclosed Ownership82,512 shares
Latest Disclosed Value $ 63,751,777
Pinnacle Associates Ltd ownership in REGN / Regeneron Pharmaceuticals, Inc.

On April 21, 2026 - Pinnacle Associates Ltd filed a 13F-HR form disclosing ownership of 82,512 shares of Regeneron Pharmaceuticals, Inc. (MX:REGN) valued at $63,751,777 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 83,741 shares of Regeneron Pharmaceuticals, Inc.. This represents a change in shares of -1.47% during the quarter.

Pinnacle Associates Ltd has a history of taking positions in derivatives of the underlying security (REGN) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:REGN / Regeneron Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 82,512 -1,229 -1.47 63,752 -1.37 0.8172
2026-02-05 2025-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 83,741 -450 -0.53 64,637 36.54 0.8293
2025-11-13 2025-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 84,191 15,265 22.15 47,338 30.82 0.6282
2025-08-04 2025-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 68,926 -12,087 -14.92 36,186 -29.58 0.5239
2025-05-06 2025-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 81,013 18,550 29.70 51,381 15.48 0.7529
2025-02-14 2024-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 62,463 -4,502 -6.72 44,495 -24.35 0.6037
2024-10-25 2024-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 66,965 611 0.92 58,815 -15.67 1.0001
2024-07-30 2024-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 66,354 -156 -0.23 69,740 8.94 1.0919
2024-04-26 2024-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 66,510 -455 -0.68 64,015 8.84 1.0089
2024-01-19 2023-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 66,965 -518 -0.77 58,815 5.90 0.9896
2023-10-24 2023-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 67,483 -2,712 -3.86 55,536 10.11 1.0323
2023-07-27 2023-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 70,195 -1,504 -2.10 50,438 -14.39 0.8752
2023-05-05 2023-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 71,699 -1,291 -1.77 58,913 11.87 1.2049
2023-02-01 2022-12-31 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 72,990 -527 -0.72 52,662 3.98 1.1475
2023-01-25 2022-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 72,074 -1,443 53,063 0.0011
2022-11-01 2022-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 73,517 -15,171 -17.11 50,644 -3.40 1.1625
2022-08-02 2022-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 88,688 -3,013 -3.29 52,426 -18.14 1.1432
2022-05-05 2022-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 91,701 -3,794 -3.97 64,046 6.20 1.1336
2022-02-02 2021-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 95,495 -1,424 -1.47 60,307 2.82 1.0403
2021-10-19 2021-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 96,919 -2,462 -2.48 58,653 5.67 1.0813
2021-08-02 2021-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 99,381 -1,110 -1.10 55,508 16.75 1.0036
2021-05-12 2021-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 100,491 -5,344 -5.05 47,546 -7.01 0.9067
2021-01-26 2020-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 105,835 -4,885 -4.41 51,130 -17.50 1.0382
2020-10-23 2020-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 110,720 -2,156 -1.91 61,979 -11.96 1.4721
2020-08-14 2020-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 112,876 -6,970 -5.82 70,395 20.29 1.7358
2020-05-13 2020-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 119,846 -21,943 -15.48 58,520 9.92 1.7777
2020-02-03 2019-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 141,789 -13,171 -8.50 53,239 23.85 1.1658
2019-11-08 2019-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 154,960 -6,944 -4.29 42,986 -15.17 1.0125
2019-08-05 2019-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 161,904 -9,312 -5.44 50,676 -27.92 1.1866
2019-05-10 2019-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 171,216 -6,236 -3.51 70,305 6.08 1.5883
2019-02-05 2018-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 177,452 -12,699 -6.68 66,278 -13.73 1.7111
2018-11-09 2018-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 190,151 -22,689 -10.66 76,829 4.63 1.5940
2018-08-08 2018-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 212,840 -28,203 -11.70 73,428 -11.54 1.5107
2018-05-11 2018-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 241,043 -3,715 -1.52 83,006 -9.79 1.6267
2018-02-12 2017-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 244,758 -19,349 -7.33 92,019 -22.08 1.7679
2017-11-13 2017-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 264,107 -3,424 -1.28 118,088 -10.13 2.1770
2017-08-09 2017-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 267,531 -11,063 -3.97 131,395 21.71 2.5253
2017-05-09 2017-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 278,594 -8,329 -2.90 107,958 2.50 2.0617
2017-02-10 2016-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 286,923 -19,060 -6.23 105,327 -14.38 2.1251
2016-11-14 2016-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 305,983 -3,454 -1.12 123,011 13.83 2.4674
2016-08-15 2016-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 309,437 620 0.20 108,065 -2.92 2.3287
2016-05-13 2016-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 308,817 5,604 1.85 111,310 -32.38 2.3810
2016-02-11 2015-12-31 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 303,213 -14,552 -4.58 164,605 11.37 3.4535
2016-02-09 2015-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 303,213 -14,552 164,605 3.5174
2015-11-10 2015-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 317,765 -54,474 -14.63 147,805 -22.16 3.2704
2015-08-12 2015-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 372,239 -42,004 -10.14 189,890 1.53 3.5253
2015-05-15 2015-03-31 13F Regeneron Pharmaceuticals COM 75886F107 414,243 -36,887 -8.18 187,022 1.05 3.4897
2015-02-12 2014-12-31 13F Regeneron Pharmaceuticals COM 75886F107 451,130 -9,560 -2.08 185,076 11.43 3.6290
2014-11-12 2014-09-30 13F Regeneron Pharmaceuticals COM 75886F107 460,690 -55,273 -10.71 166,088 13.96 3.3819
2014-08-14 2014-06-30 13F Regeneron Pharmaceuticals COM 75886F107 515,963 -29,638 -5.43 145,744 -11.04 2.8449
2014-05-14 2014-03-31 13F Regeneron Pharmaceuticals COM 75886F107 545,601 -17,899 -3.18 163,833 5.63 3.1949
2014-02-12 2013-12-31 13F Regeneron Pharmaceuticals COM 75886F107 563,500 -44,118 -7.26 155,098 -18.41 3.0283
2013-11-14 2013-09-30 13F Regeneron Pharmaceuticals COM 75886F107 607,618 -15,584 -2.50 190,105 35.65 3.9329
2013-08-13 2013-06-30 13F Regeneron Pharmaceuticals COM 75886F107 623,202 623,202 140,146 3.1496
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-05-13 2020-03-31 13F REGENERON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-03 2019-12-31 13F REGENERON PHARMACEUTICALS COM Call 900 338 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.